Stocks and securities in focus
Security | Change (%) | 1w ▲ | 1m | 1y | YTD | 3y | 5y |
---|---|---|---|---|---|---|---|
Cardiff Oncology Inc. | -5.890% | -24.049% | -42.791% | 83.353% | 135.182% | -60.321% | -11.571% |
Illumina Inc. | -5.050% | -9.055% | -11.060% | -42.117% | -18.397% | -66.785% | -63.406% |
X4 Pharmaceuticals, Inc. | -12.970% | -4.360% | -20.551% | -34.481% | 29.359% | - | - |
Intra-Cellular Therapies Inc. | -3.030% | -1.481% | 4.724% | 18.327% | 1.994% | 149.812% | 428.617% |
Viking Therapeutics Inc | 2.180% | -0.671% | 5.051% | 256.991% | 323.449% | 1449.278% | - |
Biogen Inc. | -1.170% | 1.092% | 8.212% | -29.501% | -13.656% | -9.551% | -0.780% |
BioMarin Pharmaceutical Inc. | 0.420% | 1.507% | -4.168% | -12.429% | -12.509% | 20.225% | 4.632% |
ImmunityBio Inc. | 6.240% | 2.676% | 45.727% | 53.480% | 62.585% | -44.238% | - |
Cytomx Therapeutics Inc | -5.700% | 148.564% | 99.790% | 147.273% | 172.779% | -43.752% | - |